抗整合素αvβ6自身抗体高精度区分溃疡性结肠炎与克罗恩病
这项前瞻性横断面研究纳入224例炎症性肠病患者(UC 106例,CD 118例),评估抗整合素αvβ6自身抗体区分UC与CD的诊断准确性。在2.44 U/mL截断值下,该抗体诊断准确性达86.5%,灵敏度85.8%,特异度87.1%,且独立与UC相关(OR 36.18),性能优于ANCA和ASCA。
要点
- 抗整合素αvβ6自身抗体区分UC与CD的准确性为86.5%,灵敏度85.8%,特异度87.1%。
- 该抗体与UC独立相关(OR 36.18,95%CI 17.0-83.0),诊断性能优于ANCA和ASCA。
- 抗体阳性率从回肠型CD(7.9%)向结肠型CD(43.8%)和UC(85.8%)呈梯度升高。
核心结论
- 抗整合素αvβ6自身抗体在区分UC与CD方面具有高诊断准确性,且性能优于ANCA和ASCA。
研究设计与样本
- 前瞻性横断面研究,纳入224例UC或CD患者(UC 106例,CD 118例),排除不确定性结肠炎患者,检测血清抗整合素αvβ6自身抗体、ASCA和ANCA并收集临床数据。
主要发现
- 在2.44 U/mL截断值下,抗整合素αvβ6自身抗体的诊断准确性为86.5%,灵敏度85.8%,特异度87.1%。
- 多因素Logistic回归显示该抗体独立与UC相关(OR 36.18,95%CI 17.0-83.0,p=4.86×10-19)。
- 该抗体诊断性能优于ANCA和ASCA(AIC 184.8 vs 252.4)。
- 抗体阳性率沿Montreal分类呈梯度变化:回肠型CD(L1)7.9%,回结肠型CD(L3)8.1%,结肠型CD(L2)43.8%,UC 85.8%(p=2.04×10-31)。
关键数值与推荐
- 抗整合素αvβ6自身抗体截断值为2.44 U/mL,用于区分UC与CD。
临床怎么用
- 可考虑检测血清抗整合素αvβ6自身抗体辅助鉴别UC与CD,尤其当常规血清学标志物结果不明确时。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Reliable biomarkers to distinguish ulcerative colitis (UC) from Crohn's disease (CD) remain limited. AIMS: To assess the diagnostic accuracy of anti-integrin αvβ6 autoantibodies for differentiating UC from CD and to compare their performance with anti-neutrophil cytoplasmic antibodies (ANCA) and anti-Saccharomyces cerevisiae antibodies (ASCA). METHODS: In this prospective cross-sectional study in patients with UC and CD, serum anti-integrin αvβ6 autoantibodies, ASCA, and ANCA were measured and clinical data were collected. The primary outcome was the accuracy of anti-integrin αvβ6 antibodies in distinguishing UC from CD. Secondary analyses compared their performance with ASCA and ANCA status and across IBD subgroups. RESULTS: A total of 224 patients were included (UC: n = 106, CD: n = 118, male: 63.8%, median age: 43.5 years). Patients with indeterminate colitis were excluded. At a cut-off of 2.44 U/mL, anti-integrin αvβ6 autoantibodies demonstrated a diagnostic accuracy of 86.5%, with a sensitivity of 85.8% and specificity of 87.1%. In a multivariate logistic regression analysis, these autoantibodies were independently associated with UC (OR 36.18, 95% CI 17.0-83.0, p = 4.86 × 10-19) and demonstrated superior diagnostic performance compared to ANCA and ASCA status (Akaike information criterion 184.8 vs. 252.4). Positivity rates followed a gradient across the Montreal classification, increasing from ileal (L1: 7.9%) and ileocolonic (L3: 8.1%) CD towards colonic CD (L2: 43.8%) and UC: 85.8% (p = 2.04 × 10-31). CONCLUSIONS: Anti-integrin αvβ6 autoantibodies demonstrate high diagnostic accuracy and outperform conventional serological markers in distinguishing UC from CD. Importantly, this study provides the first direct comparison with ANCA and ASCA status within the same patient cohort.
引用
- Truniger S, Waber D, Dütschler J, et al. Anti-Integrin αvβ6 Autoantibodies Distinguish Ulcerative Colitis From Crohn's Disease With High Diagnostic Accuracy and Outperform ANCA and ASCA Status: A Prospective Cross-Sectional Study. Aliment Pharmacol Ther. 2026. PMID: 42622527. doi:10.1111/apt.70926
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。